UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000000517
Receipt number R000000626
Scientific Title Study of combination chemotherapy of CPT-11/S-1 after anthracycline and taxane in recurrent or metastatic breast cancer (JBCRG-M01)
Date of disclosure of the study information 2006/11/09
Last modified on 2021/08/17 09:25:02

No. Disposal Last modified on Item of update
1 Insert 2006/11/09 08:59:35
2 Update 2006/11/09 09:00:25 UMIN ID1
3 Update 2008/06/19 16:08:49 UMIN ID2
4 Update 2008/06/23 11:31:44 Address
Organization
Division name
Address
Address
TEL
Email
Organization
Division name
Address
Address
TEL
Email
Institute
Organization1
Address1
Tel1
Email1
5 Update 2008/06/25 15:47:00 Organization
Organization
Division name
Division name
Address
Address
TEL
6 Update 2008/06/27 15:37:30 Organization
Organization
Institute
7 Update 2008/12/16 14:14:47 Email1
8 Update 2009/08/21 11:10:47 Organization
Organization
Institute
Organization1
9 Update 2009/11/11 14:09:24 Recruitment status
10 Update 2009/11/11 14:15:56 Institute
Email1
11 Update 2011/08/31 14:21:00 Recruitment status
12 Update 2011/08/31 14:21:42 Post marketing survey by drug manufacture etc., specified by Japanese law.
13 Update 2011/11/15 15:47:56 Publication of results
Other related information
Other related information
14 Update 2013/12/11 11:59:23 Last follow-up date
15 Update 2014/05/09 16:01:45 Email
Institutions
16 Update 2014/11/12 11:41:44 Address
Address
TEL
Address
Address
TEL
Address1
Tel1
17 Update 2015/05/14 13:28:14 Recruitment status
18 Update 2016/07/06 09:27:46 Name of primary person or sponsor
Organization
19 Update 2018/08/23 17:30:20 Acronym
20 Update 2018/08/24 10:01:52 UMIN ID1
UMIN ID2
21 Update 2019/11/21 16:22:09 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Organization
Zip code
Address
Homepage URL
Organization
Organization
Organization
Address
Address
Tel
Email
22 Update 2019/11/21 16:22:55 Date of IRB
23 Update 2021/08/17 09:25:02 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures